Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol

J Tureckova1, E M Wilson, J L Cappalonga

  • 1Oregon Health and Science University, Molecular Medicine Division, Department of Medicine, Portland, Oregon 97201-3098, USA.

Insights

Insulin-like growth factors (IGFs) regulate muscle differentiation via the PI 3-kinase-Akt pathway. This pathway controls myogenin expression and myotube formation, crucial for skeletal muscle development and regeneration.

Area of Science:

  • Muscle biology
  • Cell signaling
  • Molecular endocrinology

Background:

  • Skeletal muscle differentiation requires coordinated signaling pathways and myogenic transcription factors.
  • Insulin-like growth factors (IGFs) are critical for embryonic muscle development and adult muscle regeneration.
  • A novel myogenic cell line overexpressing IGF-binding protein-5 (C2BP5) was developed to study IGF action.

Purpose of the Study:

  • To elucidate the specific signaling pathways mediating IGF-I-induced muscle differentiation.
  • To identify the role of phosphatidylinositol 3-kinase (PI 3-kinase) and Akt in IGF-I signaling.
  • To investigate the relationship between IGF-I, PI 3-kinase-Akt pathway, and myogenin in muscle differentiation.

Main Methods:

  • Utilized a C2BP5 myogenic cell line that requires IGF-I for differentiation.
  • Employed the PI 3-kinase inhibitor LY294002 to block signaling pathways.
  • Expressed active PI 3-kinase and a modified Akt-1 (iAkt) to assess their effects on differentiation.
  • Studied the induction of myogenin and myotube formation.

Main Results:

  • IGF-I-induced myogenin expression and myotube formation were blocked by LY294002, even with delayed addition.
  • Active PI 3-kinase promoted differentiation independently of IGF-I.
  • Myogenin-induced differentiation was also inhibited by LY294002.
  • iAkt mimicked IGF-I's differentiation effects and rescued differentiation inhibited by LY294002.

Conclusions:

  • The PI 3-kinase-Akt pathway is essential for IGF-I-mediated skeletal muscle differentiation.
  • This pathway acts both upstream and downstream of myogenin.
  • IGF-I signaling converges on the PI 3-kinase-Akt pathway to regulate muscle development and regeneration.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...